Navigation Links
Thomson CompuMark Launches World's Most Comprehensive Trademark Search Offering for Pharmaceutical Brand Owners
Date:5/26/2010

BOSTON, May 26 /PRNewswire/ -- Thomson CompuMark, a Thomson Reuters business, today announced new, proprietary FDA drug sources in its Pharmaceutical XC Search, plus authentic FDA Phonetic Orthographic Computer Analyses (POCAs) of potential marks, both of which reduce the risk of pharmaceutical brand conflicts. This new content comprises the world's most comprehensive coverage of drug-related brands and helps companies protect their investment in creating, clearing and registering drug trademarks.  

"With so many drug names on the market, pharmaceutical brand owners face particularly complex challenges when developing new trademarks," said Martin Burke, group managing director of Thomson CompuMark. "Expanding the coverage of our industry-leading Pharmaceutical XC Search is just the latest example of how Thomson Reuters keeps brand owners, and the IP professionals who advise them, ahead of the curve, providing the most complete information to help them make better decisions and reduce their business risk."

Pharmaceutical XC Search offers:

  • Exclusive search coverage of Thomson Reuters Micromedex, including international and FDA-approved drugs, as well as the Natural Medicines Database, the gold standard for natural medicines product information
  • Additional FDA-recommended sources, including Drugs@FDA, AERS (Adverse Event Reporting System) and VAERS (Vaccine Adverse Event Reporting System) – important sources of brand names for which adverse events have been reported
  • An authentic FDA POCA of Thomson CompuMark's proprietary database featuring more than 90,000 drug names – the most extensive in the industry. Endorsed by the FDA, POCAs help clients identify pote
    '/>"/>

SOURCE Thomson CompuMark
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. Thomson Healthcare Cancer Profiler Used in Study
5. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
6. General Practitioners Write Most Prescriptions for Mental Health Drugs, According to Study from Thomson Reuters and SAMHSA
7. University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety
8. Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs
9. The University of Hong Kong Chooses ResearcherID By Thomson Reuters to Standardize Research Identifiers
10. Thomson Reuters Launches Pharmacy Intervention Solution for Hospital Pharmacists
11. Americans Losing Confidence in Their Ability to Access and Pay for Healthcare, According to Thomson Reuters Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...
(Date:5/17/2013)... NATICK, Mass. , May 17, 2013  Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...
(Date:5/16/2013)... 2013  PTC Therapeutics, Inc., today announced that it ... the U.S. Securities and Exchange Commission ("SEC") relating to ... The number of shares to be offered and the ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... book-running managers for the offering. Cowen and Company is ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
(Date:5/19/2013)... ATS 2013, PHILADELPHIA ─ Gourmands and foodies everywhere have ... a little peppery zing to both sweet and savory ... shows purified components of the spicy root also may ... , The results of the study will be presented ... characterized by bronchoconstriction, a tightening of the bronchial tubes ...
(Date:5/19/2013)... In partnership with the medical practice online marketing ... of an SEO website for dentists. The purpose of the ... , http://www.e-dentists.com/ , A perk to the service ... they see results. Dentists can request the keywords they want ... JD Media Surge, LLC rank high for competitive keywords. Dentists ...
(Date:5/19/2013)... 19, 2013 According to a ... and Forecast (2013 – 2018): By Applications (Healthcare ... Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) And ... sensor market was $8.00 billion in 2012 and ... at an estimated CAGR of 3.84% from 2013 ...
(Date:5/19/2013)... York (PRWEB) May 19, 2013 The ... Case Management Conference was recently convened for hundreds of ... multidistrict litigation now underway in U.S. District Court, Southern ... the Court’s website on May 14th, the Conference addressed ... was also reported during the Conference that Defendants submitted ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier ... the launch it's all new vacation packages for the ... 5/19/2013. Consumers traveling to Las Vegas will be pleased ... VegasHotelEscapes.com's website. Travelers will be pleased to know that ... , Vegas Hotel Escapes specializes in helping consumers ...
Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... with quadriplegia, mutism and lower cranial nerve paralysis ... others is through vertical gaze and upper eyelid ... the June issue of Mayo Clinic Proceedings ... locked-in syndrome who also had dancing eye syndrome ...
... Rare variant may lead immune system to attack healthy ... -- A new study finds that rare gene variations ... the immune system attacks the body. These autoimmune disorders ... report that the findings could lead to better treatments ...
... ... been costly, confusing and time consuming. As a result, nearly 75% of ... all. Nearly half of all resources dedicated to new product development ... consumer packaged goods manufacturers can now launch an investigation of consumer product ...
... Boomers seeking help for drug abuse, study finds , WEDNESDAY, ... older, admissions for drug abuse treatment have nearly doubled between ... cocaine, heroin, prescription drugs, and/or marijuana abuse among men and ... 1992 to just over 12 percent by 2008, according to ...
... limited to the mouth, smokeless tobacco affects the normal ... almost every organ in the body, according to the ... Chemical Research in Toxicology . The enzymes play ... hormones estrogen and testosterone; production of cholesterol and vitamin ...
... disease receive laxatives after being treated with narcotics, despite ... These are the findings from a Nationwide Children,s Hospital ... in Pediatric Blood & Cancer . Narcotic-related ... in hospitalized children and constipation is a frequent narcotic-associated ...
Cached Medicine News:Health News:Mayo Clinic Proceedings: Gabapentin opens window of communication 2Health News:Gene Mutations Offer Clues to Autoimmune Disorders 2Health News:Marketing Research for Companies That Don't Do Marketing Research 2Health News:Marketing Research for Companies That Don't Do Marketing Research 3Health News:'Graying' of Drug Users at U.S. Treatment Centers 2Health News:Sickle cell patients should be better monitored for constipation prevention 2
VerdaSee Dock Door Portal ID solutions provide high performance tracking of assets that enter or leave healthcare facilities through dock doors....
VerdaSee Portal ID is a family of solutions that provide automated tracking and tracing of assets as they enter or leave designated areas within a healthcare facility....
The AeroScout Exciter extends the AeroScout system to provide robust and sophisticated RFID detection capabilities....
... Exit Alerting System, instantly help ... and assets (e.g. medical equipment), ... throughout your facility. With this ... quickly ensured the cost savings, ...
Medicine Products: